Thomas Flaten

Stock Analyst at Lake Street

(3.10)
# 1,315
Out of 5,043 analysts
31
Total ratings
42.42%
Success rate
4.51%
Average return

Stocks Rated by Thomas Flaten

Evaxion
Oct 20, 2025
Maintains: Buy
Price Target: $6$11
Current: $6.13
Upside: +79.45%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42$70
Current: $38.24
Upside: +83.05%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9$13
Current: $8.02
Upside: +62.09%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $2.95
Upside: +171.19%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11$14
Current: $6.88
Upside: +103.49%
Aytu BioPharma
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.21
Upside: +261.99%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $60$40
Current: $6.65
Upside: +501.50%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $40$35
Current: $23.96
Upside: +46.08%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10$8
Current: $7.00
Upside: +14.29%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7$9
Current: $9.68
Upside: -7.02%
Maintains: Buy
Price Target: $4$3
Current: $0.81
Upside: +269.78%
Maintains: Buy
Price Target: $19$11
Current: $4.68
Upside: +135.04%
Maintains: Buy
Price Target: $34$25
Current: $28.04
Upside: -10.84%
Maintains: Buy
Price Target: $14,400$1,440
Current: $2.14
Upside: +67,189.72%